MIB-1, a monoclonal antibody against proliferation-associated nuclear antigen, in AF ranged from 2.9 to 7.5% and from 1.5 to 13.5% in the epithelial and mesenchymal components, respectively. Here, MIB1 is linked to atrial fibrillation.